Sean:
It really shouldn't come as any surprise that shareholders have once again been delivered underwhelming news regarding trial results for a critical catalyst in company/drug development.

To quote Lalezari " Cytodyn is the most inept company I've ever dealt with, hands down win the prize for most ineffectual group" - with the canning of NP ( and hopefully rid Kelly as well ) the new leadership can push something to the finish line- More than six years and still in holding pattern with HIV- Taken far too long for the next Humira to get into hands of physicians and patients